Transcriptional activity of genes encoding Transforming Growth Factor β and its receptors in peripheral blood mononuclear cells from patients with acute coronary syndromes

International Journal of Cardiology

Volumn 111, Issue 2, 2006, Pages 275-279

  Dabek, Jozefa ^a   Mazurek, Urszula ^a   Gasior, Zbigniew ^a   Wilczok, Tadeusz ^a   Kulach, Andrzej ^a   Kucia Kuzma, Sylwia ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Acute coronary syndromes; Gene expression; Transforming growth factor

Indexed keywords

MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE ACTIVITY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; HEART INFARCTION; HUMAN; HUMAN CELL; PATHOPHYSIOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TRANSCRIPTION REGULATION; UNSTABLE ANGINA PECTORIS;

ADULT; AGED; ANGINA, UNSTABLE; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMERASE CHAIN REACTION; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REFERENCE VALUES; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 33746271972     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.10.006     Document Type: Article

References (18)

1. Javelaud D., and Mauviel A. Mammalian transforming growth factor-betas: Smad signaling and physio-pathological roles. Int J Biochem Cell Biol 36 (2004) 1161-1165
2. Miyazono K. Transforming growth factor-beta and its receptors. Nippon Yakurigaku Zasshi 107 (1996) 133-140
3. Argmann C.A., Van Den Diepstraten C.H., Sawyez C.G., et al. Transforming growth factor-β1 inhibits macrophage cholesteryl ester accumulation induced by native and oxidized VLDL remnants. Arterioscler Thromb Vasc Biol 21 (2001) 2011-2018
4. Gojova A., Brun V., Esposito B., et al. Specific abrogation of transforming growth factor-β signaling in T cells alters atherosclerotic lesion size and composition in mice. Blood (2003)
5. Mallat Z., Gojova A., Marchiol-Fournigault C., et al. Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ Res 89 (2001) 930-934
6. Lutgens E., Gijbels M., Smook M., et al. Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression. Arterioscler Thromb Vasc Biol 22 (2002) 975-982
7. Grainger D.J. Transforming growth factor beta and atherosclerosis: so far, so good for the protective cytokine hypothesis. Arterioscler Thromb Vasc Biol 24 (2004) 399-404
8. McCaffrey T.A., Consigli S., Du B., et al. Decreased type II / type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-β1. J Clin Invest 96 (1995) 2667-2675
9. Djurovic S., Thelle D.S., Ringstad J., Christensen B., and Berg K. Altered serum concentrations of TGF-beta 1 and Lp(a) lipoprotein and their correlation in patients with first acute myocardial infarction. Nutr Metab Cardiovasc Dis 9 (1999) 250-254
10. Grainger D.J., Kemp P.R., Liu A.C., Lawn R.M., and Metcalfe J.C. Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice. Nature 370 (1994) 460-462
11. Byrne C.D., Wareham N.J., Martensz N.D., Humphries S.E., Metcalfe J.C., and Grainger D.J. Increased PAI activity and PAI-1 antigen occurring with an oral fat load: associations with PAI-1 genotype and plasma active TGF-β levels. Atherosclerosis 140 (1998) 45-53
12. Chen K., Metha J.K., Li D., Joseph L., and Joseph J. Transforming growth factor-β receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II. Circ Res 95 (2004) 1167-1173
13. Ikeuchi M., Tsutsui H., Shiomi T., et al. Inhibition of TGF-beta signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction. Cardiovasc Res 64 (2004) 526-535
14. Tzanidis A., Lim S., Hannan R.D., See F., Ugoni A.M., and Krum H. Combined angiotensin and endothelin receptor blockade attenuates adverse cardiac remodeling post-myocardial infarction in the rat: possible role of transforming growth factor β1. J Mol Cell Cardiol 33 (2001) 969-981
15. Kuwahara F., Kai H., Tokuda K., et al. Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation 106 (2002) 130-135
16. Cipollone F., Fazia M., Mincione G., et al. Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. Stroke 35 (2004) 2253-2257
17. Grainger D.J., Heathcote K., Chiano M., et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 8 (1999) 93-97
18. Yokota M., Ichihara S., Lin T.L., Nakashima N., and Yamada Y. Association of a T29→C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 101 (2000) 2783-2787